$AIMD

Ainos, Inc.

1
1
0

No SEC Form 4 filings for $AIMD in the last 30 days.

Low

Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets

Ainos, Inc. (NASDAQ:AIMD) reported second-quarter 2026 results for the quarter ended June 30 and updated investors on AI Nose deployments. The company said AI Nose expanded across semiconductor manufacturing, industrial and healthcare infrastructure, and robotics, building smell data. It cited about 613 million industrial smell records accumulated since Dec. 2025, and referenced an initial $2.1 million commercial arrangement.

Ainos, Inc. (AIMD): Results of Operations and Financial Condition

Ainos, Inc. (AIMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) (“Ainos” or the “Company”) today announced resu

Ainos Expands Smell AI With Growing Real

Ainos, Inc. (NASDAQ:AIMD) said its AI Nose deployments have generated about 613 million industrial scent data points since December 2025, mainly from semiconductor manufacturing. The company says the data supports its Smell AI platform by refining proprietary Smell IDs and its Smell Language Model, and it plans to expand into other industries.

AIMD sentiment & insider activity

Over the past 7 days, alphai's AI scored 2 news stories mentioning AIMD (Ainos, Inc.). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.

Recent AIMD coverage spans insider activity, technology and earnings.

What's driving AIMD

  • The update is a company-specific execution and deployment progress read-through, but it lacks hard financial figures in the provided text.

    itnewsonline.com · Aug 4, 2026

  • The filing is a company-specific update emphasizing deployment momentum and dataset growth, but it provides no new financial figures in the scraped text.

    SEC EDGAR 8-K · Aug 3, 2026

  • The update is a dataset scale milestone for Ainos Smell AI, but it does not include revenue, contracts, or clinical/biotech progress.

    itnewsonline.com · Jul 21, 2026

  • The 8-K creates incremental near-term funding and associated interest expense, which can affect liquidity risk and near-term financing expectations.

    SEC EDGAR 8-K · Jul 9, 2026

  • The disclosed research program expands Ainos’ AI Nose from environmental sensing to breath intelligence for differentiating COPD exacerbations vs heart failure.

    itnewsonline.com · Jun 22, 2026

alphai scores every news story that mentions AIMD with an AI model for sentiment and relevance, and aggregates insider trades from Ainos, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AIMD

Score

Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets

Ainos, Inc. (NASDAQ:AIMD) reported second-quarter 2026 results for the quarter ended June 30 and updated investors on AI Nose deployments. The company said AI Nose expanded across semiconductor manufacturing, industrial and healthcare infrastructure, and robotics, building smell data. It cited about 613 million industrial smell records accumulated since Dec. 2025, and referenced an initial $2.1 million commercial arrangement.

Ainos, Inc. (AIMD): Results of Operations and Financial Condition

Ainos, Inc. (AIMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) (“Ainos” or the “Company”) today announced resu

Ainos Expands Smell AI With Growing Real

Ainos, Inc. (NASDAQ:AIMD) said its AI Nose deployments have generated about 613 million industrial scent data points since December 2025, mainly from semiconductor manufacturing. The company says the data supports its Smell AI platform by refining proprietary Smell IDs and its Smell Language Model, and it plans to expand into other industries.

Ainos, Inc. (AIMD): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Ainos, Inc. (AIMD) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. false 0001014763 0001014763 2026-07-03 2026-07-03 0001014763 AIMD:CommonStockParValue0.01PerShareMember 2026-07-03 2026-07-03 0001014763 AIMD:WarrantsToPurchaseCommonStockMember 2026-07-03 2026-07-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND E

Ainos, Inc.: VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Ainos, Inc. (NASDAQ:AIMD) said VASRO GmbH highlighted its AI Nose platform’s expansion into live emergency department operations. VASRO reports a research program at an Asia academic medical center to generate 2,500+ hours of emergency-department environmental scent data for overcrowding early warning and respiratory infection risk analysis. The initiative broadens evaluations beyond industrial settings and supports Ainos’ Smell Language Model development.

Related tickers